Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 5 studies | 24% ± 6% | |
| astrocyte | 5 studies | 22% ± 5% | |
| kidney loop of Henle epithelial cell | 4 studies | 25% ± 9% | |
| oligodendrocyte precursor cell | 4 studies | 26% ± 6% | |
| GABAergic neuron | 3 studies | 26% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 3199.31 | 2642 / 2642 | 99% | 112.63 | 697 / 705 |
| kidney | 100% | 4059.51 | 89 / 89 | 98% | 90.84 | 879 / 901 |
| skin | 37% | 399.72 | 672 / 1809 | 35% | 14.83 | 163 / 472 |
| adrenal gland | 1% | 4.23 | 2 / 258 | 22% | 9.07 | 51 / 230 |
| adipose | 14% | 81.35 | 173 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 11% | 125.13 | 163 / 1445 | 1% | 0.12 | 1 / 183 |
| stomach | 8% | 49.00 | 28 / 359 | 1% | 0.18 | 3 / 286 |
| uterus | 0% | 0 | 0 / 170 | 6% | 3.98 | 28 / 459 |
| ovary | 1% | 2.48 | 1 / 180 | 4% | 2.57 | 18 / 430 |
| blood vessel | 2% | 9.68 | 32 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 2% | 6.29 | 16 / 966 | 1% | 0.09 | 3 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.49 | 1 / 45 |
| breast | 2% | 6.65 | 7 / 459 | 1% | 0.18 | 7 / 1118 |
| prostate | 1% | 31.02 | 3 / 245 | 0% | 0.03 | 1 / 502 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.43 | 7 / 504 |
| thymus | 0% | 0.79 | 1 / 653 | 0% | 0.10 | 3 / 605 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.17 | 1 / 178 |
| lung | 0% | 0 | 0 / 578 | 1% | 0.34 | 6 / 1155 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.15 | 2 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071918 | Biological process | urea transmembrane transport |
| GO_0021869 | Biological process | forebrain ventricular zone progenitor cell division |
| GO_0072233 | Biological process | metanephric thick ascending limb development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0072227 | Biological process | metanephric macula densa development |
| GO_0072218 | Biological process | metanephric ascending thin limb development |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0072236 | Biological process | metanephric loop of Henle development |
| GO_0007417 | Biological process | central nervous system development |
| GO_0072240 | Biological process | metanephric DCT cell differentiation |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0048878 | Biological process | chemical homeostasis |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0021799 | Biological process | cerebral cortex radially oriented cell migration |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0071837 | Molecular function | HMG box domain binding |
| Gene name | POU3F3 |
| Protein name | POU domain, class 3, transcription factor 3 (Brain-specific homeobox/POU domain protein 1) (Brain-1) (Brn-1) (Octamer-binding protein 8) (Oct-8) (Octamer-binding transcription factor 8) (OTF-8) |
| Synonyms | OTF8 BRN1 |
| Description | FUNCTION: Transcription factor that acts synergistically with SOX11 and SOX4. Plays a role in neuronal development . Is implicated in an enhancer activity at the embryonic met-mesencephalic junction; the enhancer element contains the octamer motif (5'-ATTTGCAT-3') (By similarity). . |
| Accessions | ENST00000361360.4 ENST00000674056.1 P20264 |